Eosinophil-guided corticosteroid therapy in patients admitted to hospital with COPD exacerbation (CORTICO-COP): a multicentre, randomised, controlled, open-label, non-inferiority trial

医学 慢性阻塞性肺病 恶化 皮质类固醇 甲基强的松龙 泼尼松龙 内科学 嗜酸性粒细胞 支气管扩张剂 不利影响 随机对照试验 哮喘
作者
Pradeesh Sivapalan,Thérèse Sophie Lapperre,Julie Janner,Rasmus Rude Laub,Mia Moberg,Charlotte Sandau Bech,Josefin Eklöf,Freja Stæhr Holm,Karin Armbruster,Praleene Sivapalan,Christiane Mosbech,Aras K M Ali,Niels Seersholm,Jon Torgny Wilcke,Eva Brøndum,Tine Peick Sonne,Finn Rønholt,Helle Frost Andreassen,Charlotte Suppli Ulrik,Jørgen Vestbo,Jens‐Ulrik Stæhr Jensen
出处
期刊:The Lancet Respiratory Medicine [Elsevier]
卷期号:7 (8): 699-709 被引量:130
标识
DOI:10.1016/s2213-2600(19)30176-6
摘要

Background Treatment with systemic corticosteroids in patients with acute exacerbations of chronic obstructive pulmonary disease (COPD) is associated with debilitating adverse effects. Therefore, strategies to reduce systemic corticosteroid exposure are urgently required and might be offered by a personalised biomarker-guided approach to treatment. The aim of this study was to determine whether an algorithm based on blood eosinophil counts could safely reduce systemic corticosteroid exposure in patients admitted to hospital with acute exacerbations of COPD. Methods We did a multicentre, randomised, controlled, open-label, non-inferiority trial at the respiratory departments of three different university-affiliated hospitals in Denmark. Eligible participants were patients included within 24h of admission to the participating sites, aged at least 40 years, with known airflow limitation (defined as a post-bronchodilator FEV1/forced vital capacity [FVC] ratio ≤0·70) and a specialist-verified diagnosis of COPD, who were designated to start on systemic corticosteroids by the respiratory medicine physician on duty. We randomly assigned patients (1:1) to either eosinophil-guided therapy or standard therapy with systemic corticosteroids. Both investigators and patients were aware of the group assignment. All patients received 80 mg of intravenous methylprednisolone on the first day. The eosinophil-guided group were from the second day given 37·5 mg of prednisolone oral tablet daily (for a maximum of up to 4 days) on days when their blood eosinophil count was at least 0·3 × 109 cells per L. On days when the eosinophil count was lower, prednisolone was not administered. If a patient was discharged during the treatment period, a treatment based on the last measured eosinophil count was prescribed for the remaining days within the 5-day period (last observation carried forward). The control group received 37·5 mg of prednisolone tablets daily from the second day for 4 days. The primary outcome was the number of days alive and out of hospital within 14 days after recruitment, assessed by intention to treat (ITT). Secondary outcomes included treatment failure at day 30 (ie, recurrence of acute exacerbation of COPD resulting in emergency room visits, admission to hospital, or need to intensify pharmacological treatment), number of deaths on day 30, and duration of treatment with systemic corticosteroids. The non-inferiority margin was 1·2 days (SD 3·8). This trial is registered at ClinicalTrials.gov, number NCT02857842, and was completed in January, 2019. Findings Between Aug 3, 2016, and Sept 30, 2018, 159 patients in the eosinophil-guided group and 159 patients in the control group were included in the ITT analyses. There was no between-group difference for days alive and out of hospital within 14 days after recruitment: mean 8·9 days (95% CI 8·3–9·6) in the eosinophil-guided group versus 9·3 days (8·7–9·9) in the control group (absolute difference –0·4, 95% CI −1·3 to 0·5; p=0·34). Treatment failure at 30 days occurred in 42 (26%) of 159 patients in the eosinophil-guided group and 41 (26%) of 159 in the control group (difference 0·6%, 95% CI −9·0 to 10·3; p=0·90). At 30 days nine patients (6%) of 159 in the eosinophil-guided group and six (4%) of 159 in the control group had died (difference 1·9%, 95% CI −2·8 to 6·5; p=0·43). Median duration of systemic corticosteroid therapy was lower in the eosinophil-guided group: 2 days (IQR 1·0 to 3·0) compared with 5 days (5·0 to 5·0) in the control group, p<0·0001. Interpretation Eosinophil-guided therapy was non-inferior compared with standard care for the number of days alive and out of hospital, and reduced the duration of systemic corticosteroid exposure, although we could not entirely exclude harm on some secondary outcome measures. Larger studies will help to determine the full safety profile of this strategy and its role in the management of COPD exacerbations. Funding The Danish Regions Medical Fund and the Danish Council for Independent Research.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
你好发布了新的文献求助10
1秒前
嗯好22222完成签到 ,获得积分10
10秒前
睡觉王完成签到 ,获得积分10
12秒前
巫巫巫巫巫完成签到 ,获得积分10
35秒前
握瑾怀瑜完成签到 ,获得积分0
37秒前
陈无敌完成签到 ,获得积分10
39秒前
星空完成签到 ,获得积分10
42秒前
研友_8Y26PL完成签到 ,获得积分10
42秒前
海孩子完成签到,获得积分10
43秒前
Tong应助wangzhihao采纳,获得10
45秒前
菠萝谷波完成签到 ,获得积分10
45秒前
科研顺完成签到 ,获得积分10
46秒前
蓝桉完成签到 ,获得积分10
53秒前
刘天虎研通完成签到 ,获得积分10
54秒前
Dingz完成签到,获得积分10
56秒前
gg完成签到,获得积分10
1分钟前
张包子完成签到 ,获得积分10
1分钟前
孤独听雨的猫完成签到 ,获得积分10
1分钟前
1分钟前
陈秋完成签到,获得积分10
1分钟前
鬼见愁应助科研通管家采纳,获得10
1分钟前
皮卡丘完成签到 ,获得积分10
1分钟前
hailiangzheng完成签到,获得积分10
1分钟前
陈秋发布了新的文献求助10
1分钟前
成就的孤晴完成签到 ,获得积分10
1分钟前
Airhug完成签到 ,获得积分10
1分钟前
陶冶完成签到,获得积分10
1分钟前
FashionBoy应助刘隅采纳,获得10
1分钟前
Vegeta完成签到 ,获得积分10
1分钟前
SAINT完成签到 ,获得积分10
1分钟前
Patrick完成签到 ,获得积分10
1分钟前
overlood完成签到 ,获得积分10
1分钟前
没头脑和不高兴完成签到 ,获得积分10
1分钟前
Byby完成签到 ,获得积分10
1分钟前
qausyh完成签到,获得积分10
2分钟前
xzn1123应助wodetaiyangLLL采纳,获得10
2分钟前
lixinyue完成签到 ,获得积分10
2分钟前
JamesPei应助研友_LN32Mn采纳,获得10
2分钟前
快乐的幼丝完成签到 ,获得积分10
2分钟前
我独舞完成签到 ,获得积分10
2分钟前
高分求助中
좌파는 어떻게 좌파가 됐나:한국 급진노동운동의 형성과 궤적 2500
Sustainability in Tides Chemistry 1500
TM 5-855-1(Fundamentals of protective design for conventional weapons) 1000
Cognitive linguistics critical concepts in linguistics 800
Threaded Harmony: A Sustainable Approach to Fashion 799
Livre et militantisme : La Cité éditeur 1958-1967 500
氟盐冷却高温堆非能动余热排出性能及安全分析研究 500
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3052652
求助须知:如何正确求助?哪些是违规求助? 2709874
关于积分的说明 7418267
捐赠科研通 2354446
什么是DOI,文献DOI怎么找? 1246020
科研通“疑难数据库(出版商)”最低求助积分说明 605951
版权声明 595921